Helios Diagnostic & Healthcare Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
as on 05-07-2024
- Paid Up Capital ₹ 2.50 M
as on 05-07-2024
- Company Age 17 Year, 7 Months
- Last Filing with ROC 31 Mar 2018
- Open Charges ₹ 30.90 M
as on 05-07-2024
- Revenue -45.39%
(FY 2018)
- Profit 12.35%
(FY 2018)
- Ebitda 7.29%
(FY 2018)
- Net Worth -16.25%
(FY 2018)
- Total Assets 4.56%
(FY 2018)
About Helios Diagnostic & Healthcare
The Corporate was formerly known as Helios Diagnostic Healthcare Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2018. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 2.50 M.
The company currently has active open charges totaling ₹3.09 Cr.
Saumabha Dasgupta and Dola Dasgupta serve as directors at the Company.
- CIN/LLPIN
U85110WB2007PTC113737
- Company No.
113737
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Feb 2007
- Date of AGM
29 Sep 2018
- Date of Balance Sheet
31 Mar 2018
- Listing Status
Unlisted
- ROC Code
Roc Kolkata
Industry
Company Details
- Location
Kolkata, West Bengal, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Helios Diagnostic & Healthcare?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Saumabha Dasgupta  | Director | 28-Feb-2007 | Current |
| Dola Dasgupta | Director | 25-Jun-2010 | Current |
Financial Performance and Corporate Structure Insights of Helios Diagnostic & Healthcare.
Helios Diagnostic & Healthcare Private Limited, for the financial year ended 2018, experienced significant reduction in revenue, with a 45.39% decrease. The company also saw a substantial improvement in profitability, with a 12.35% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.25%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Helios Diagnostic & Healthcare?
In 2018, Helios Diagnostic & Healthcare had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Ge Capital Services India Creation Date: 26 Aug 2008 | ₹1.30 Cr | Open |
Hdfc Bank Limited Creation Date: 02 May 2007 | ₹3.80 M | Open |
State Bank Of India Creation Date: 16 Apr 2007 | ₹1.41 Cr | Open |
How Many Employees Work at Helios Diagnostic & Healthcare?
Unlock and access historical data on people associated with Helios Diagnostic & Healthcare, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Helios Diagnostic & Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Helios Diagnostic & Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
